Latest Breaking News On - Pharmacovigilance programme - Page 1 : comparemela.com

International Patients Union signs MoU with IPC to prioritise patient-driven healthcare solutions - News Healthcare

International Patients Union signs MoU with IPC to prioritise patient-driven healthcare solutions - News Healthcare
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Rajendra pratap guptaRajeev raghuvanshiIndian pharmacopoeia commissionDigital health associatesPharmacovigilance programme of india pvInternational patient unionPharmacovigilance programme of indiaUnion health ministerPatients union appChange initiativeUnion healthPharmacovigilance programmeBorn hearing screeningFundamental right issueAutism awareness dayAdverse drug

Should parents worry about using Meftal syrups to treat fever in children?

Indian Pharmacopoeia Commission (IPC) issued a drug safety alert for painkiller ‘Meftal’. Here are some pointers that parents should know to treat fever in kids | Health

Rajath athreyaIndian pharmacopoeia commissionPharmacovigilance programme of india pvPharmacovigilance programmeMefenamic acidSenior consultantSakra world hospitalChildhood feversParacetamol safetyMenstrual crampsRheumatoid arthritisAdverse drug reaction

Evening briefing: Supreme Court s stern view on Gujarat flogging | Latest News India

A shortlist of the biggest headlines, recommended stories, and a collection of news events to check out. | Latest News India

New delhiSouth africaAndhra pradeshUttar pradeshLata mangeshkar chowkSandeep mehtaRam templeBhushanr gavaiRahul dravidRam lallaRam janmabhoomiIndian pharmacopoeia commissionSupreme courtPharmacovigilance programme of india pvSupreme court onRam path

IPC alert advises patients to monitor possibility of mefenamic acid s adverse effects: Meftal makers

IPC alert advises patients to monitor possibility of mefenamic acid s adverse effects: Meftal makers
moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomPharmacovigilance programme of india pvIndian pharmacopoeia commissionAcross laboratoriesPharmacovigilance programmeIpc alertMeftal spasBlue cross laboratories

Meftal painkiller: Meftal maker says adverse reaction flagged by IPC is very rare

Blue Cross Laboratories, the owner of the Meftal painkiller brand, has clarified that the adverse reaction the Indian Pharmacopoeia Commission (IPC) has flagged is a rare event. The company claims that the product s constituent, mefenamic acid, can cause adverse reactions, including eosinophilia and systemic symptoms (DRESS) syndrome.

United kingdomPvpi pharmacovigilance programmeIndian pharmacopoeia commissionBlue cross laboratoriesAcross laboratoriesPharmacovigilance programmeMeftal painkillerIpc safety alertIndian pharmacopoeia commission ipc